# EDGAR Filing Document

**Accession Number:** 0001868640
**File Stem:** 0001493152-25-022601
**Filing Date:** 2025-11
**Character Count:** 33591
**Document Hash:** 338f64d3186866da1db074300e305cf2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-022601.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001493152-25-022601

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20251114

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Roadzen Inc.
- **CENTRAL INDEX KEY:** 0001868640
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 981600102
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41094
- **FILM NUMBER:** 251481437

**BUSINESS ADDRESS:**
- **STREET 1:** 111 ANZA BLVD., SUITE 109
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010
- **BUSINESS PHONE:** 650-414-3530

**MAIL ADDRESS:**
- **STREET 1:** 111 ANZA BLVD., SUITE 109
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vahanna Tech Edge Acquisition I Corp.
- **DATE OF NAME CHANGE:** 20210621

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): November 14, 2025**

**ROADZEN INC.**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **British Virgin Islands** | **001-41094** | **98-1600102** |
| **(State or Other Jurisdiction**<br> **of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **111 Anza Blvd**<br> **Suite 109** |  |
| **Burlingame** **, California** | **94010** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (**347) 745-6448**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Ordinary Shares, par value $0.0001 per share | RDZN | The Nasdaq Stock Market LLC |
| Warrants, each warrant exercisable for one ordinary share, each at an exercise price of $11.50 per share | RDZNW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02 Results of Operations and Financial Condition.**

On November 14, 2025, Roadzen Inc. (the "Company") issued a press release announcing its financial results for the three and six months ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

This information is intended to be furnished under Item 2.02 of Form 8-K, "Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit Number** | **Description of Exhibit** |
| 99.1 | [Press release issued on November 14, 2025.](ex99-1.htm) |
| 104 | Cover page interactive data file (embedded within the Inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **ROADZEN INC.** | **ROADZEN INC.** |
| Date: | November 14, 2025 | By: | */s/ Jean-Noël Gallardo* |
|  |  | Name:<br> Title: | Jean-Noël Gallardo<br> Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Roadzen Reports $13.7 Million Second Quarter Revenue, a 15.2% Improvement Over Prior Year Quarter, and Fifth Consecutive Quarter of Adjusted EBITDA Improvement.**

***Company continues growth momentum, reduces net loss 90.3% over prior year quarter, and accelerates path to Adjusted EBITDA breakeven***

---

| | |
|:---|:---|
| ● | **Improving Fiscal Q2 and Record Six-Month Revenue** |
|  | Revenue increased 25.9% sequentially and 15.2% year-over-year to $13.7 million; six-month revenue rose 18.0% to $24.5 million, reporting a record first half and best quarter in the last 12 months. |
| ● | **Sharply Reduced Net Loss and Fifth Straight Quarter of Adjusted EBITDA**<sup>1</sup> **Improvement** |
|  | Q2 net loss narrowed to $(2.1) million from $(21.8) million the same quarter last year, a 90.3% year-over-year improvement. Adjusted EBITDA loss improved to $(1.1) million from $(2.1) million from the prior year quarter — a 48.6% year-over-year improvement. |
| ● | **Balance Sheet Strengthened Through Premium Capital Raises** |
|  | Over $9 million in additional capital was raised at premiums to market during the quarter, including funding at the India subsidiary level implying a $2 per share valuation for Roadzen's Nasdaq share price. |
| ● | **Debt Extension Agreement in Principle – Post Second Quarter** |
|  | In November, the Mizuho $11.5 million senior debt facility was agreed in principle to be extended from December 31, 2025 to June 30, 2027. |
| ● | **Series of Strategic Wins Strengthen Global Expansion** |
|  | DrivebuddyAI achieved EU regulatory validation and surpassed 3.5 billion kilometers of real-world driving data. Roadzen also secured a major European OEM insurance mandate and signed a definitive agreement to acquire a majority interest in a U.S. commercial auto Managing General Underwriter, reinforcing its position as a global leader at the intersection of AI, insurance, and mobility. |

---

NEW YORK, November 14, 2025 (GLOBE NEWSWIRE) – Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the three and six months ended September 30, 2025.

"This was a very strong quarter for Roadzen, building on the momentum from last quarter — both in business performance and in strengthening our balance sheet," said Rohan Malhotra, CEO and founder of Roadzen. "We raised over $11.5 million in the last four months with minimal dilution to shareholders, from some of the world's leading technology investors, delivered our fifth consecutive quarter of Adjusted EBITDA improvement, and achieved a 90.3% year-over-year reduction in net loss. Several key partnerships and contracts are set to come in, positioning us for accelerated momentum in the second half."

<sup>1</sup> *Adjusted EBITDA is a non-GAAP financial metric. See "Non-GAAP Financial Measures" at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.*

 

Malhotra continued, "With over 3.5 billion kilometers of driving data powering DrivebuddyAI and more than 2.5 million claims and inspections processed annually through our platform, Roadzen now operates at a data scale unmatched in our industry. This depth of data and industrial knowledge in insurance is fueling our precision AI — built for mobility and insurance. We've asked our investors to track three things: our growth and path to breakeven, our leadership in innovation, and the addition of marquee client partnerships across geographies. We are confident we will deliver on these goals and continue to believe the Company is poised for sustained growth ahead."

"This was a strong quarter for Roadzen, reflecting disciplined cost management and meaningful operational improvements. During the quarter, and with the subsequent final close of the India subsidiary funding, we continued to strengthen our balance sheet, providing the runway to reach operational cash flow breakeven," stated Jean-Noël Gallardo, CFO of Roadzen Inc. "Following quarter-end, we agreed in principle with Mizuho to extend our debt facility, further enhancing our financial flexibility and removing a significant short-term liability. Combined with ongoing AI-driven efficiencies and targeted expense optimization, we are confident this momentum will drive continued margin expansion and stronger cash flow in the second half of fiscal 2026."

**<u>Second Quarter and Year to Date Financial Highlights</u>**

**Revenue and Key Performance Indicators:**

● Revenue
 for the second quarter totaled $13.7 million, increasing approximately $1.8 million, or 15.2%, over the prior year quarter. Revenue
 for the six months ended September 30, 2025 was $24.5 million, increasing approximately 18.0% over the same period last year.

● As
 of September 30, 2025, Roadzen had 46 insurance customer agreements (including carriers, self-insureds and other entities processing
 insurance claims), 80 automotive customer agreements, and approximately 3,900 agents and fleet customer agreements. This compares
 to 34 insurance, 74 automotive and 3,550 agent and fleet customers as of September 30, 2024.

● Roadzen's
 brokerage business sold 116,528 policies during the second quarter generating $12.4 million of Gross Written Premium ("GWP"),
 compared to 70,618 policies in the same quarter last year, which produced $10.1 million of GWP.

● In
 our IaaS business, 754,207 claims, roadside assistance and vehicle inspections were conducted during the three months ending September
 30, 2025, compared to 607,577 for the same period in the prior year.

● Gross
 margin for the quarter ended September 30, 2025 was 55.7% compared to 56.1% reported in the same quarter last year.

**Net Results:** 

● Net
 loss for the second quarter totaled $(2.1) million or $(0.03) per share, compared to a net loss of $(21.8) million or $(0.32) per
 share in the same quarter last year, which included approximately $19.7 million of non-cash, non-recurring and other extraordinary
 items.

● Fiscal
 year to date, net loss totaled $(6.1) million or $(0.08) per share, compared to a net loss of $(70.2) million or $(1.03) per share
 in the same period last year.

● Adjusted
 EBITDA loss for the quarter was $(1.1) million compared to a loss of $(2.1) million in the same quarter last year, and a loss of
 $(1.4) million for the first quarter of fiscal 2026. This second quarter marks Roadzen's fifth sequential improvement in quarterly
 Adjusted EBITDA.

**<u>Other Financial Developments</u>**

○ $2.25 million private placement from some of the Company's largest shareholders at a 20% premium to the closing price;

○ $2.25 million registered direct offering from an institutional investor completed on the back of the first fund raise; and

○ $4.5 million raised through the first tranche of its India subsidiary financing, subsequently upsized to $7 million due to strong investor demand. The upsized transaction valued the subsidiary at $91 million post-money, implying approximately a $2 per share for Roadzen's Nasdaq-listed shares. The round was led by marquee institutional investors including Team India, Quant AMC, Valentis Advisors, and Prime Securities Group, along with leading capital markets investors such as Utpal Sheth and Anand Jain.

**<u>Second Fiscal Quarter 2026 Operational Highlights</u>**

**Contract and Partnership Announcements:**

● Roadzen
 announced its partnership with a top global two-wheeler (motorcycles and scooter) OEM to
 launch real-time connected roadside assistance for a new line of electric and connected vehicles
 across India. The OEM partner serves over 100 million vehicles globally, including more than
 60 million two-wheelers in India and over 5 million new vehicles sold annually in the country
 where two-wheelers dominate the mobility landscape.

**<u>Subsequent Operational Developments</u>**

**DrivebuddyAI Developments:**

● Roadzen's
 DrivebuddyAI achieved official validation for its Driver Monitoring System ("DMS")
 for compliance with the European Union General Safety Regulation (EU GSR 2144) by the authorized
 testing laboratory Applus IDIADA in Barcelona, Spain. This certification expands DrivebuddyAI's
 regulatory compliance footprint beyond India's AIS-184 standard, making it the only
 AI-powered driver monitoring platform validated under both Indian and European regulations.
 The validation comes ahead of the EU NCAP 2026 mandates requiring in-cabin driver monitoring
 for all new vehicles beginning July 2026.

● DrivebuddyAI's
 dataset surpassed 3.5 billion kilometers of real-world driving data—nearly doubling
 in just four months. This extensive data has consistently demonstrated a 70%+ reduction in
 accidents, validating the platform's ability to improve driver behavior, fleet safety,
 and risk management for insurers and mobility operators worldwide.

● DrivebuddyAI
 secured five-year contracts with six leading small and medium sized trucking fleets in India
 to equip over 1,500 Volve and BharatBenz vehicles with its advanced Driver Monitoring System
 and Collision Warning AI. Valued in the mid-seven figures (USD), the deals include hardware,
 subscription-based software, and 24-7 Command Centre for real-time driver oversight and accident
 prevention. Full deployment is slated for March 2026.

**Contract and Partnership Announcements:**

● Roadzen
 was awarded a mandate to serve as a Managing General Agent for one of the world's top
 five auto manufacturers to manage its insurance program in a major European market, representing
 over $20 million in annual GWP. Roadzen will manage administration, claims, and payments
 for the automaker's insurance operations, earning fees that are expected to contribute
 more than 15% of GWP as recurring revenue to Roadzen. Expected to launch next quarter and

 embedded digital policy management, automated claims, and real-time analytics, integrated
 seamlessly into the automaker's ecosystem.

**Acquisition Announcement:**

● Roadzen
 signed a definitive agreement to acquire majority control of a U.S.-based commercial auto
 insurance broker and Managing General Underwriter operating in California, Texas, Illinois,
 and New Jersey, with Lloyd's of London Coverholder status. The business, which reached
 a $15 million annualized premium run rate within seven months, serves 90+ fleets via an expanding
 network of 300+ agents and adds six new carrier relationships.

● Post-closing,
 it will integrate its offerings with DrivebuddyAI and National Auto Club, combining telematics,
 roadside assistance, claims, and insurance distribution into a uniquely positioned U.S. commercial
 auto platform. Operating on a commission- and fee-based model with no underwriting risk,
 it earns 15–25% of premiums per policy, plus fee income and profit share. The acquisition
 is expected to close this quarter, is non-dilutive, projected to generate $30 million+ in
 annual premiums and $8 million in revenues with a 25% net margin in the first year, and scale
 to $150 million GWP with 25%+ net margins within three years, establishing the U.S. as Roadzen's
 second-largest market.

For more information about Roadzen Inc., please visit https://roadzen.ai.

**About Roadzen Inc.**

Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences.

Thousands of clients — from the world's leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. Roadzen's pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world's top AI innovators.

Headquartered in Burlingame, California, Roadzen employs more than 300 people across offices in the U.S., U.K., and India. Learn more at www.roadzen.ai.

**Cautionary Statement Regarding Forward Looking Statements**

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," and "continue," or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, anticipated benefits and revenues from the partnership described in this press release, business growth in the U.S., U.K. and India, anticipated Adjusted EBITDA breakeven timing, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, our agreement in principle to extend the maturity date of our debt with Mizuho, our ability to consummate the planned transaction with a U.S.-based commercial insurance broker, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in "Risk Factors" in our Securities and Exchange Commission ("SEC") filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

**For more information, please contact:**

Investor Contacts: IR@roadzen.ai

Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai

**Roadzen Inc.**

**Unaudited Condensed Consolidated Balance Sheets**

**(in US $, except share count)**

---

| | | |
|:---|:---|:---|
| <br>**Particulars** | **As of September 30,**<br>**2025** | **As of March 31,**<br>**2025** |
| **Assets** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 4973633 | 4836576 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 2648485 | 2625385 |
| &nbsp;&nbsp;&nbsp;Inventories | 213875 | 202535 |
| &nbsp;&nbsp;&nbsp;Prepayments and other current assets | 25913502 | 19092595 |
| &nbsp;&nbsp;&nbsp;Investments | 366487 | 197805 |
| **Total current assets** | **34115982** | **26954896** |
| **Non current assets** |  |  |
| &nbsp;&nbsp;&nbsp;Restricted cash | 219746 | 217064 |
| &nbsp;&nbsp;&nbsp;Non marketable securities | 268764 | 269470 |
| &nbsp;&nbsp;&nbsp;Property and equipment, net | 591781 | 602923 |
| &nbsp;&nbsp;&nbsp;Goodwill | 2298287 | 2061553 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 1272406 | 1109219 |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | 2638248 | 1243253 |
| &nbsp;&nbsp;&nbsp;Other long-term assets | 144643 | 120972 |
| **Total Non current assets** | **7433875** | **5624454** |
| **Total assets** | **41549857** | **32579350** |
| **Liabilities and shareholders' Equity/(Deficit)** |  |  |
| **Current liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Current portion of long-term borrowings | 2831559 | 2904444 |
| &nbsp;&nbsp;&nbsp;Short-term borrowings | 20194849 | 19865645 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 33237612 | 30254010 |
| &nbsp;&nbsp;&nbsp;Derivative warrant liabilities | 1339967 | 1489818 |
| &nbsp;&nbsp;&nbsp;Short-term operating lease liabilities | 463347 | 318921 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 3219831 | 2102466 |
| **Total current liabilities** | **61287165** | **56935304** |
| **Non current liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Long-term borrowings | 147874 | 139775 |
| &nbsp;&nbsp;&nbsp;Long-term operating lease liabilities | 413863 | 628400 |
| &nbsp;&nbsp;&nbsp;Other long-term liabilities | 551817 | 566651 |
| **Total Non current liabilities** | **1113554** | **1334826** |
| **Total liabilities** | **62400719** | **58270130** |
| **Commitments and contingencies (refer note 22)** |  |  |
| **Shareholders' Equity/(Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of September 30, 2025 and March 31, 2025; 76,021,755, and 74,290,986 shares outstanding as of September 30, 2025 and March 31, 2025 respectively | 99195750 | 95501291 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (229940316) | (223826442) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income/(loss) | (1133485) | (468859) |
| &nbsp;&nbsp;&nbsp;Other components of equity | 103853847 | 103720113 |
| **Total shareholders' deficit** | **(28024204)** | **(25073897)** |
| Share Application Money | 1084289 |  |
| Non-controlling interest | 6089053 | (616883) |
| **Total deficit** | **(20850862)** | **(25690780)** |
| **Total liabilities and Total Deficit** | **41549857** | **32579350** |

---

The accompanying notes are an integral part of these consolidated financial statements.

**Roadzen Inc.**

**Unaudited Condensed Consolidated Statements of Operations**

**(in US $, except share count)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the three months ended <br> September 30,** | **For the three months ended <br> September 30,** | **For the six months ended <br> September 30,** | **For the six months ended <br> September 30,** |
| <br>**Particulars** | **2025** | **2024** | **2025** | **2024** |
| **Revenue** | 13679267 | 11874098 | 24544813 | 20805615 |
| **Costs and expenses:** |  |  |  |  |
| Cost of services | 6057579 | 5217621 | 10527032 | 10645061 |
| Research and development | 148529 | 1496600 | 230063 | 3286142 |
| Sales and marketing | 6252328 | 8076959 | 12384339 | 13879257 |
| General and administrative | 3806800 | 20430960 | 6384698 | 46257148 |
| Depreciation and amortization | 750207 | 193372 | 875206 | 673721 |
| **Total costs and expenses** | **17015443** | **35415512** | **30401338** | **74741329** |
| **Loss from operations** | **(3336176)** | **(23541414)** | **(5856525)** | **(53935714)** |
| Interest expense (net) | (1249540) | (626834) | (2190859) | (1448520) |
| Fair value gains/(losses) in financial instruments carried at fair value | 1067732 | (1096949) | 556194 | (18249009) |
| Other income (net) | 1353929 | 3252528 | 1306007 | 3274880 |
| **Total other income/(expense)** | **1172121** | **1528745** | **(328658)** | **(16422649)** |
| **Loss before income taxes and equity-method investment activity** | **(2164055)** | **(22012669)** | **(6185183)** | **(70358363)** |
| Equity method investment activity, net |  |  |  |  |
| **(Loss)/Income before income tax expense** | **(2164055)** | **(22012669)** | **(6185183)** | **(70358363)** |
| Less: income tax (benefit)/expense | 10826 | (181264) | 90805 | (74614) |
| Income tax expense | 15640 | 4214 | 50589 | 17147 |
| Deferred tax expense | (4814) | (185478) | 40216 | (91761) |
| **Net (loss)/income before non-controlling interest** | **(2174881)** | **(21831405)** | **(6275988)** | **(70283749)** |
| Net loss attributable to non-controlling interest, net of tax | (66777) | (21366) | (162114) | (66685) |
| **Net Loss attributable to Ordinary shareholders** | **(2108104)** | **(21810039)** | **(6113874)** | **(70217064)** |
| **Net loss per share attributable to Ordinary shareholders** |  |  |  |  |
| Basic and diluted | (0.03) | (0.32) | (0.08) | (1.03) |
| Weighted-average number of shares used in computing net loss per share | 75671838 | 68440829 | 75671838 | 68440829 |

---

The accompanying notes are an integral part of these consolidated financial statements.

**Roadzen Inc.** 

**Unaudited Condensed Consolidated Statements of Cash Flow** 

**(in US $, except share count)** 

---

| | | |
|:---|:---|:---|
| | **For the six months ended <br> September 30,** | **For the six months ended <br> September 30,** |
| <br>Particulars | **2025** | **2024** |
| Cash flows from operating activities |  |  |
| Net loss per share attributable to Ordinary shareholders | **(6113874)** | **(70217064)** |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 875206 | 673721 |
| &nbsp;&nbsp;&nbsp;Stock based compensation | 133734 | 46977256 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | (1263) | (223516) |
| &nbsp;&nbsp;&nbsp;Unrealised foreign exchange loss/(profit) | (62074) | 101374 |
| &nbsp;&nbsp;&nbsp;Fair value losses/(profits) in financial instruments carried at fair value | (556194) | 18249009 |
| &nbsp;&nbsp;&nbsp;Expected credit loss (net of reversal) | 25572 | (112451) |
| &nbsp;&nbsp;&nbsp;Balances written off/(back) | (1331258) | (3200441) |
| &nbsp;&nbsp;&nbsp;Net loss attributable to non-controlling interest, net of tax | (162114) | (66685) |
| Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: |  |  |
| &nbsp;&nbsp;&nbsp;Inventories | (11340) | (20836) |
| &nbsp;&nbsp;&nbsp;Income taxes, net |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivables, net | 417176 | 380405 |
| &nbsp;&nbsp;&nbsp;Prepayments and other assets | (6073975) | 2018036 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 3107115 | (1554615) |
| &nbsp;&nbsp;&nbsp;Other liabilities | 754275 | (4255358) |
| Net cash used in operating activities | **(8999014)** | **(11251165)** |
| Cash flows from investing activities |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment, intangible assets and goodwill | (355635) | 39443 |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of mutual fund |  | 193606 |
| &nbsp;&nbsp;&nbsp;Investment in mutual funds and bonds | (28213) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from forward purchase agreement | - | 1000000 |
| Net cash used in investing activities | **(383848)** | **1233049** |
| Cash flows from financing activities |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issue of ordinary shares | 3694459 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issue of ordinary shares of subsidiary to the Non-controlling interest | 5778944 |  |
| &nbsp;&nbsp;&nbsp;Net proceeds/(payments) from long term borrowings | (47093) |  |
| &nbsp;&nbsp;&nbsp;Net proceeds/(payments) from short-term borrowings | (894769) | 4460327 |
| Net cash generated from financing activities | **8531541** | **4460327** |
| Effect of exchange rate changes on cash and cash equivalents | 62972 | 2368 |
| Net (decrease)/increase in cash and cash equivalents (including restricted cash) | **(788349)** | **(5555421)** |
| Cash acquired in business combination | 928074 |  |
| Cash and cash equivalents at the beginning of the period (including restricted cash) | 5053654 | 11565088 |
| Cash and cash equivalents at the end of the period (including restricted cash) | **5193379** | **6009667** |
| Reconciliation of cash and cash equivalents |  |  |
| Cash and cash equivalents | 4973633 | 5992238 |
| Restricted cash | 219746 | 17429 |
| Total cash and cash equivalents | **5193379** | **6009667** |
| Supplemental disclosure of cash flow information |  |  |
| Cash paid for interest, net of amounts capitalized | 1707711 | 885011 |
| Non-cash investing and financing activities |  |  |
| Consideration payable in connection with acquisitions | 488000 | 488000 |
| Interest accrued on borrowings | 2652119 | 317597 |

---

The accompanying notes are an integral part of these consolidated financial statements.

**Non-GAAP Financial Measures**

This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain non-recurring and other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flows provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.

Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.

The following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:

---

| | | |
|:---|:---|:---|
| | **For the three months ended <br> September 30,** | **For the three months ended <br> September 30,** |
| <br>**Particulars** | **2025** | **2024** |
| **Net loss** | **(2108104)** | **(21810039)** |
| Adjusted for: |  |  |
| Other (income)/expense net | (1353929) | (3252528) |
| Interest (income)/expense | 1249540 | 626834 |
| Fair value changes in financial instruments carried at fair value<sup>(1)</sup> | (1067732) | 1096949 |
| Tax (benefit)/expense | 10826 | (181264) |
| Depreciation and amortization | 750207 | 193372 |
| Stock based compensation expense | 62381 | 20746267 |
| Non-cash expenses | 132841 | 351130 |
| Non-recurring expenses | 1231747 | 105725 |
| **Adjusted EBITDA** | **(1092224)** | **(2123554)** |

---

---

| | | |
|:---|:---|:---|
| | **For the six months ended <br> September 30,** | **For the six months ended <br> September 30,** |
| <br>**Particulars** | **2025** | **2024** |
| **Net loss** | **(6113874)** | **(70217064)** |
| Adjusted for: |  |  |
| Other (income)/expense net | (1306007) | (3274880) |
| Interest (income)/expense | 2190859 | 1448520 |
| Gain on bargain purchase |  |  |
| Fair value changes in financial instruments carried at fair value<sup>(1)</sup> | (556194) | 18249009 |
| Tax (benefit)/expense | 90805 | (74614) |
| Depreciation and amortization | 875206 | 673721 |
| Stock based compensation expense | 133739 | 46977256 |
| Non-cash expenses | 439555 | 636190 |
| Non-recurring expenses | 1747849 | 630483 |
| **Adjusted EBITDA** | **(2498062)** | **(4951379)** |

---